Steven Cohen Karyopharm Therapeutics Inc. Transaction History

Point72 Asset Management, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.14 - $1.81 $310 - $492	272 New	272 $0
Q1 2023 May 15, 2023	SELL	$2.84 - $3.92 $5.66 Million - $7.81 Million	-1,991,613 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $4.93 Million - $11.8 Million	1,988,113 Added 56803.23%	1,991,613 $6.77 Million
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $14,280 - $20,370	3,500 New	3,500 $19,000
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $4.95 Million - $6.01 Million	-349,723 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $4.95 Million - $6.89 Million	349,723 New	349,723 $5.11 Million
Q3 2019 Nov 15, 2019	SELL	$5.66 - $11.85 $14.7 Million - $30.8 Million	-2,596,323 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.32 - $6.43 $11.2 Million - $16.7 Million	2,596,323 New	2,596,323 $15.6 Million
Q1 2019 May 15, 2019	SELL	$4.12 - $10.25 $6.35 Million - $15.8 Million	-1,541,718 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.2 - $16.95 $5.67 Million - $11.7 Million	691,225 Added 81.27%	1,541,718 $14.4 Million
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $10.1 Million - $12.5 Million	-591,690 Reduced 41.03%	850,493 $14.5 Million
Q2 2018 Aug 14, 2018	SELL	$12.0 - $19.88 $6.2 Million - $10.3 Million	-516,344 Reduced 26.36%	1,442,183 $24.5 Million
Q1 2018 May 15, 2018	SELL	$9.92 - $17.25 $13.8 Million - $24 Million	-1,393,469 Reduced 41.57%	1,958,527 $26.3 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $30.7 Million - $40.2 Million	3,351,996	3,351,996 $32.2 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.